Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMDW) Interest Expenses (2019 - 2025)

Historic Interest Expenses for Revolution Medicines (RVMDW) over the last 5 years, with Q3 2025 value amounting to $11.4 million.

  • Revolution Medicines' Interest Expenses changed N/A to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 39683.16%. This contributed to the annual value of $2.5 million for FY2024, which is 73432.34% up from last year.
  • As of Q3 2025, Revolution Medicines' Interest Expenses stood at $11.4 million.
  • Revolution Medicines' Interest Expenses' 5-year high stood at $11.4 million during Q3 2025, with a 5-year trough of $12000.0 in Q1 2021.
  • Over the past 3 years, Revolution Medicines' median Interest Expenses value was $2.7 million (recorded in 2024), while the average stood at $4.2 million.
  • Data for Revolution Medicines' Interest Expenses shows a peak YoY increase of 4285.71% (in 2021) and a maximum YoY decrease of 4285.71% (in 2021) over the last 5 years.
  • Over the past 3 years, Revolution Medicines' Interest Expenses (Quarter) stood at $12000.0 in 2021, then surged by 20966.67% to $2.5 million in 2024, then surged by 352.06% to $11.4 million in 2025.
  • Its last three reported values are $11.4 million in Q3 2025, $2.5 million for Q4 2024, and $2.8 million during Q1 2024.